02184nas a2200205 4500008004100000245007400041210006900115260001800184300001200202490000600214520154700220653002801767653001501795653001701810653001101827653002801838100002501866700002901891856005801920 2020 eng d00aDermatology Medications Therapeutic Interchanges: A Narrative Reviews0 aDermatology Medications Therapeutic Interchanges A Narrative Rev cNovember 2020 a124-1270 v93 a

Objective: To review the dermatology medications therapeutic interchanges therapy. Methods: It is an extensive search, or fifty databases comprised the following through the Saudi Digital Library (SDL) searching engine. It included the various types of studies (meta-analysis, randomized controlled studies and observational studies) in the English language with human study only for the update May 2017. The search in terms of therapeutic interchange, medication, therapy and type of disease or medication base on therapeutics class of anti-psychiatric. The medication list and switch from one drug to substitute based on the literature found the search that has included comparative safety, efficacy and cost of the type of medication for each disease and national or international evidence-based guidelines. Results: The total number of studies after an extensive search with a specific term search was 487 studies. Of those, there were 107 duplicated studies, and 380 studies included for future assessment. After assessment, 375 Records were excluded due to Non dermatology therapeutics interchange. Of the previous search, there were 5 studies that had been found discussed the dermatology medications therapeutic interchanges. Conclusion: There were few studies about medications used in skin disorder therapeutic interchange. It is better to start for generic substitutes and based on the international Therapeutic dermatology guidelines.

10aDermatology Medications10aInitiative10aSaudi Arabia10aSystem10aTherapeutic Interchange1 aAlomi, Yousef, Ahmed1 aBahadig, Faiz, Abdullah. uhttps://ijphs.org/article/2020/9/4/105530ijpcs2020925